Mesenchymal Stem Cells (MSCs): A Novel Therapy for Type 2 Diabetes

Although plenty of drugs are currently available for type 2 diabetes mellitus (T2DM), a subset of patients still failed to restore normoglycemia. Recent studies proved that symptoms of T2DM patients who are unresponsive to conventional medications could be relieved with mesenchymal stem/stromal cell...

Full description

Saved in:
Bibliographic Details
Main Authors: Shuang Gao, Yuanyuan Zhang, Kaini Liang, Ran Bi, Yanan Du
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2022/8637493
Tags: Add Tag
No Tags, Be the first to tag this record!